Just a moment...

Top
Help
Upgrade to AI Search

We've upgraded AI Search on TaxTMI with two powerful modes:

1. Basic
Quick overview summary answering your query with referencesCategory-wise results to explore all relevant documents on TaxTMI

2. Advanced
• Includes everything in Basic
Detailed report covering:
     -   Overview Summary
     -   Governing Provisions [Acts, Notifications, Circulars]
     -   Relevant Case Laws
     -   Tariff / Classification / HSN
     -   Expert views from TaxTMI
     -   Practical Guidance with immediate steps and dispute strategy

• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.Help Us Improve - by giving the rating with each AI Result:

Explore AI Search

Powered by Weblekha - Building Scalable Websites

×

By creating an account you can:

Logo TaxTMI
>
Call Us / Help / Feedback

Contact Us At :

E-mail: [email protected]

Call / WhatsApp at: +91 99117 96707

For more information, Check Contact Us

FAQs :

To know Frequently Asked Questions, Check FAQs

Most Asked Video Tutorials :

For more tutorials, Check Video Tutorials

Submit Feedback/Suggestion :

Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
TMI Blog
Home / RSS

Boehringer Ingelheim India Announces Partnership with Alivira Animal Health Limited

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....oehringer Ingelheim India Announces Partnership with Alivira Animal Health Limited<BR>PTI News<BR>Dated:- 23-1-2026<BR>PTI<BR>Mumbai, Maharashtra, India – Business Wire India Boehringer Ingelheim India Private Limited has entered into an agreement with Alivira Animal Health Limited (a fully owned subsidiary of Viyash Scientific Limited) for the distribution and promotion of its companion animal ....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....products portfolio in India. This partnership will leverage the growth opportunities in Indian pet healthcare market that is driven by increased pet ownership, awareness of preventive care and growing emphasis on animal well-being in India. Speaking on the partnership, Dr. Vinod Gopal, Country Head, Animal Health, Boehringer Ingelheim India, said, “This partnership aligns with our long-term gr....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....owth strategy for the animal health business in India and enables us to serve our customers with greater clarity, consistency, and care. It positions us to scale efficiently while remaining focused on strategic leadership. Alivira Animal Health Limited will expand our sales capability across urban and rural India in the companion animal business, further enhancing market reach, access and driving ....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....execution excellence.” He further adds, “Our portfolio continues to be built on high-quality products, supported by a robust and advancing pipeline, ensuring sustainable growth, strong governance, and consistent delivery for our customers. Together with Alivira Animal Health Limited, we can improve access, and responsiveness while preserving a clear strategy and brand experience to support the....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

.... future growth of our companion animal business.” Dr. Haribabu Bodepudi, MD & Group CEO - Viyash Scientific Limited, said, “This represents an important milestone in Viyash Scientific’s journey to become a key player in the companion animal segment. India offers tremendous opportunities for innovative medicines which cater to the medical needs of our pets. Driving access to high quality solu....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....tions for our pets in urban and rural India is at the heart of this partnership. Alivira’s extensive geographical reach and on-ground capabilities, combined with Boehringer Ingelheim’s differentiated companion animal product portfolio strengthens our ability to serve veterinarians and pet parents across India effectively.” About Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutica....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....l company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

.... to build a healthier, more sustainable, and equitable tomorrow. Established in 2003, Boehringer Ingelheim India manages operations in India and neighbouring markets, offering innovative products in Human Pharma and Animal Health, with key therapy areas including diabetes, cardiovascular, and respiratory conditions. Learn more at https://www.boehringer-ingelheim.com/in About Alivira Animal Healt....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....h Limited Alivira Animal Health Limited is a wholly owned subsidiary of Viyash Scientific Limited (formerly known as Sequent Scientific Limited). Headquartered in India, the company is among the top 25 Animal Health companies in the world. With over 3000 talented employees, Viyash Scientific Limited is an integrated pharmaceutical company having a rich portfolio of formulations and APIs for human ....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....and veterinary use, serving customers in over 100 countries. Viyash and its subsidiaries have manufacturing, R&D and distribution operations across India, Spain, Brazil, Turkey and USA, with approvals from international regulatory bodies, including USFDA, EUGMP, WHO, TGA, etc. Pursuant to approvals from the Registrar of Companies, SeQuent Scientific Limited has been officially renamed as Viyash ....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....Scientific Limited with effect from January 8, 2026, marking the completion of the merger between Sequent Scientific Limited and Viyash Life Sciences Private Limited. To View the Image, Click on the Link Below: (L-R) Rajaram Narayanan, CEO-Animal Health Viyash Scientific Limited, Meenal Gauri, GM and Head of Human Pharma, Boehringer Ingelheim India, Dr. Vinod Gopal, Head of Animal Health, Boehri....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....nger Ingelheim India (Disclaimer: The above press release comes to you under an arrangement with Business Wire India and PTI takes no editorial responsibility for the same.). PTI PWR PWR<BR> News - Press release - PIB....